Stefano Comai

Stefano Comai

McGill University

H-index: 35

North America-Canada

About Stefano Comai

Stefano Comai, With an exceptional h-index of 35 and a recent h-index of 29 (since 2020), a distinguished researcher at McGill University, specializes in the field of Neuroscience, Mood disorders, Sleep, Tryptophan metabolism, biological markers.

His recent articles reflect a diverse array of research interests and contributions to the field:

Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLD

The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy

Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms

Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders

Dopamine neuron dysfunction and loss in the PrknR275W mouse model of Juvenile Parkinsonism

Probing the association between cognition, suicidal behavior and tryptophan metabolism in a sample of individuals living with bipolar disorder: a secondary analysis

Stefano Comai Information

University

Position

Neurobiological Psychiatry Unit Department of Psychiatry Qc Canada

Citations(all)

4662

Citations(since 2020)

3244

Cited By

2483

hIndex(all)

35

hIndex(since 2020)

29

i10Index(all)

72

i10Index(since 2020)

59

Email

University Profile Page

McGill University

Google Scholar

View Google Scholar Profile

Stefano Comai Skills & Research Interests

Neuroscience

Mood disorders

Sleep

Tryptophan metabolism

biological markers

Top articles of Stefano Comai

Title

Journal

Author(s)

Publication Date

Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLD

Digestive and Liver Disease

S De Martin

D Gabbia

M Colognesi

A Rinaldi

L Cascione

...

2024/2/1

The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy

Schizophrenia Research

Jacopo Sapienza

Giulia Agostoni

Stefano Dall'Acqua

Stefania Sut

Sofia Nasini

...

2024/2/1

Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms

BMC medicine

Stefano Comai

Nicolas Nunez

Tobias Atkin

Maykel F Ghabrash

Rita Zakarian

...

2024/1/25

Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome

British Journal of Pharmacology

Antonio Inserra

Giada Giorgini

Sebastien Lacroix

Antonella Bertazzo

Jocelyn Choo

...

2023/3

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users

Translational Psychiatry

Megan J Shram

Jack E Henningfield

Glen Apseloff

Charles W Gorodetzky

Sara De Martin

...

2023/6/7

Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders

Journal of Clinical Psychopharmacology

Christophe Moderie

Jacob D King

Nicolas Nuñez

Stefano Comai

Gabriella Gobbi

2023/11/1

Dopamine neuron dysfunction and loss in the PrknR275W mouse model of Juvenile Parkinsonism

bioRxiv

Maria Regoni

Letizia Zanetti

Martina Sevegnani

Chiara Domenicale

Stefano Magnabosco

...

2023

Probing the association between cognition, suicidal behavior and tryptophan metabolism in a sample of individuals living with bipolar disorder: a secondary analysis

Brain sciences

Pasquale Paribello

Alessio Squassina

Claudia Pisanu

Anna Meloni

Stefano Dall’Acqua

...

2023/4/20

Esmethadone-HCl (REL-1017): a promising rapid antidepressant

Maurizio Fava

Stephen M Stahl

Sara De Martin

Andrea Mattarei

Ezio Bettini

...

2023/10

Substantially elevated serum glutamate and CSF GOT-1 levels associated with cerebral ischemia and poor neurological outcomes in subarachnoid hemorrhage patients

Scientific Reports

Silvia Snider

Luigi Albano

Filippo Gagliardi

Stefano Comai

Francesca Roncelli

...

2023/3/31

Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies

Jacopo Sapienza

Marco Spangaro

Gilles J Guillemin

Stefano Comai

Marta Bosia

2023/9

Biological factors underpinning suicidal behaviour: an update

Maya N Abou Chahla

Mahmoud I Khalil

Stefano Comai

Lena Brundin

Sophie Erhardt

...

2023/3/16

Activation of Kv7 channels normalizes hyperactivity of the VTA-NAcLat circuit and attenuates methamphetamine-induced conditioned place preference and sensitization in mice

Molecular Psychiatry

E Liu

Kunkun Pang

Min Liu

Xu Tan

Zhaofang Hang

...

2023/8/21

Exploring the association among the tryptophan to serotonin and kynurenine pathways, cognition and suicidal behaviour: a secondary analysis in a sample of individuals affected …

European Psychiatry

P Paribello

M Manchia

A Squassina

C Pisanu

D Congiu

...

2023/3

Age-Related Effects of Exogenous Melatonin on Anxiety-like Behavior in C57/B6J Mice

Biomedicines

Sofia Nasini

Sara Tidei

Atea Shkodra

Danilo De Gregorio

Marco Cambiaghi

...

2023/6/13

Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study

Pharmacological Research

Margherita Tassan Mazzocco

Claudia Pisanu

Luigi Russo

Clementina Acconcia

Marco Cambiaghi

...

2023/12/1

Hypnotic Effects of Melatonergic Compounds Measured in Mice or Rats

Stefano Comai

Danilo De Gregorio

2022/10/1

Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression

European Neuropsychopharmacology

Stefano Comai

Elisa Melloni

Cristina Lorenzi

Irene Bollettini

Benedetta Vai

...

2022/2/1

Sex differences in responses to antidepressant augmentations in treatment-resistant depression

Christophe Moderie

Nicolas Nuñez

Allan Fielding

Stefano Comai

Gabriella Gobbi

2022/6/1

Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds

Danilo De Gregorio

Stefano Comai

2022/10/1

See List of Professors in Stefano Comai University(McGill University)